Hydrochloric Acid

Hydrochloric Acid

SCHEMBL23497490

NCc1nc2c(F)cccc2[nH]1.[Cl-].[H+]

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ EGLN1 Q9GZT9 1/20 0.40
▸ SLC40A1 Q9NP59 7/20 0.38
▸ MGAM O43451 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ SI P14410 1/20 0.38
▸ MGAM2 Q2M2H8 1/20 0.38
▸ CACNA1H O95180 1/20 0.37
▸ PARP1 P09874 1/20 0.37
▸ IDO1 P14902 1/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ CHEK1 O14757 1/20 0.36
▸ HTR2A P28223 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4270442 0.97 EGLN1 (0.42) EGLN1SLC40A1MGAMGAASI
Hydrochloric Acid SCHEMBL23497492 0.95 EGLN1 (0.41) EGLN1SLC40A1MGAMGAASI
Hydrochloric Acid SCHEMBL23782097 0.95 EGLN1 (0.41) EGLN1SLC40A1MGAMGAASI
SCHEMBL5744116 0.79 EGLN1 (0.42) EGLN1SLC40A1MGAMGAASI
SCHEMBL4061481 0.79 MGAM (0.40) EGLN1SLC40A1MGAMGAASI
SCHEMBL17308357 0.79 DDAH1 (0.53) EGLN1SLC40A1MGAMGAASI
SCHEMBL7001717 0.78 CHEK1 (0.49) EGLN1SLC40A1MGAMGAASI
SCHEMBL5736933 0.77 CHEK1 (0.55) GAACACNA1HPARP1NPC1RAB9A
SCHEMBL22075724 0.77 SLC40A1 (0.40) EGLN1SLC40A1MGAMGAASI
Hydrochloric Acid SCHEMBL6999319 0.76 GAA (0.51) EGLN1SLC40A1MGAMGAASI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230117034-A1 PYRAZOLOTRIAZINES BAYER AKTIENGESELLSCHAFT (DE) 2023-04-20 — — US disclosed
EP-4073072-A1 PYRAZOLOTRIAZINES Bayer Aktiengesellschaft (DE) 2022-10-19 — — EP disclosed
WO-2021116178-A1 PYRAZOLOTRIAZINES BAYER AKTIENGESELLSCHAFT (DE) 2021-06-17 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230117034-A1 PYRAZOLOTRIAZINES BRCA1, TPX2, CCND2 EGLN1 2442/4885SLC40A1 3466/4885MGAM 4716/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback